Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(v) mice

Journal of Rheumatology

Volumn 26, Issue 12, 1999, Pages 2628-2634

  Yamamoto, Toshiyuki ^a   Takahashi, Yuichi ^a   Takagawa, Shinsuke ^a   Katayama, Ichiro ^b   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Animal model; Bleomycin; Fibrosis; Mast cell; Sclerosis

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOPSY; BLEOMYCIN; CELL COUNT; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HISTAMINE; HYDROXYPROLINE; INTERLEUKIN-4; MAST CELLS; MICE; MICE, MUTANT STRAINS; SCLERODERMA, SYSTEMIC; SCLEROSIS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032708703     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Krieg T, Meurer M. Systemic scleroderma. Clinical and pathophysiologie aspects. J Am Acad Dermatol 1988;18:457-81.
2. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
3. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
4. Gruber BL. Mast cells: Accessory cells which potentiate fibrosis. Intern Rev Immunol 1995;12:259-79.
5. Hawkins RA, Claman HN, Clark RAF, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985;102:182-6.
6. Nishioka K, Kobayashi Y, Katayama I, Takijiri C. Mast cell numbers in diffuse seleroderma. Arch Dermatol 1987;123:205-8.
7. Thompson HL, Bubelo PD, Gabriel G, Yamada Y, Metcalfe DD. Murine mast cells synthesize basement membrane components: a possible role in early fibrosis. J Clin Invest 1991;87:619-23.
8. Walker M, Harley R, LeRoy EC. Inhibition of fibrosis in TSK mice by blocking mast cell degranulation. J Rheumatol 1987;14:299-301.
9. Walker M, Harley R, LeRoy EC. Ketotifen prevents skin fibrosis in the tight skin mouse. J Rheumatol 1990;17:57-9.
10. Everett ET, Pablos JL, Harley RA, LeRoy EC, Norris JS. The role of mast cells in the developing of skin fibrosis in tight-skin mutant mice. Comp Biochem Physiol 1995;110:159-65.
11. Adamson IVR, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Pathol 1974;77:185-98.
12. Aso Y, Yoneda K, Kikkawa Y. Morphological and biological study of pulmonary changes induced by bleomycin in mice. Lab Invest 1976;35:558-68.
13. Chandler DB. Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 1990;11:21-30.
14. Goto T, Befus D, Low R, Bienenstock J. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis in rats. Am Rev Respir Dis 1984;130:797-802.
15. Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999;112:456-62.
16. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum 1992;35:67-72.
17. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961;93:440-7.
18. Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 1988;43:552-8.
19. Russel JD, Russel SB, Truplin KM. The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol 1977;93:389-94.
20. Hatamochi A, Ueki H, Mauch C, Krieg T. Effect of histamine of collagen and non-collagen mRNA production in human skin fibroblasts. J Dermatol Sci 1991;2:407-12.
21. Nagata Y, Matsumura F, Motoyoshi H, Yamasaki H, Fukuda K, Tanaka S. Secretion of hyaluronic acid from synovial fibroblasts is enhanced by histamine: a newly observed metabolic effect of histamine. J Lab Clin Med 1992;120:707-12.
22. Falanga V, Soter NA, Altman RD, Kerdel FA. Elevated plasma histamine levels in systemic sclerosis (scleroderma). Arch Dermatol 1990;126:336-8.
23. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991;88:493-9.
24. Gruber BL, Kew RR, Jelaska A, et al. Human mast cells activate fibroblasts. Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997;158:2310-7.
25. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99:1313-21.
26. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
27. Moller A, Lippert D, Lessman D, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
28. Galli SJ, Gordon JR, Wershie BK. Mast cell cytokines in allergy and inflammation. Agents Actions 1993;43 Suppl:209-20.
29. Selvan RS, Butterfield JH, Krangel MS. Expression of multiple chemokine genes by human mast cell leukemia. J Biol Chem 1994;269:13893-8.
30. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72:215-22.
31. Qu Z, Liebler JM, Powers MR, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995;147:564-73.
32. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc ε RI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J Exp Med 1994;180:2027-37.
33. Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH. Endothelial leukocyte adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991;146:521-8.
34. Klein LM, Lavker RM, Matis WL, Murphy GF. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 1989;86:8972-6.
35. Meng H, Marchese MJ, Garlick JA, et al. Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. J Invest Dermatol 1995;105:789-96.
36. Monroe JG, Haldar S, Prystowsky MB, Lammie P. Lymphokine regulation of inflammatory process: Interleukin-4 stimulates fibroblast proliferation. Clin Immunol Immunopathol 1988;49:292-8.
37. Fertin C, Nicolas JF, Gillery P, Kalis B, Banchereau J, Maquart FX. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol 1991;37:823-9.
38. Horiuchi T, Ohta K, Yamaguchi M, et al. Mast cell involvement in bleomycin induced lung injury of mice [abstract]. Am Rev Respir Dis 1990;142:A498.
39. O'Brien-Ladner A, Wesselius LJ, Stechshulte DJ. Decreased lung collagen deposition in mast cell deficient mice after bleomycin [abstract]. Am Rev Respir Dis 1990;142:A499.
40. V mice and mechanism of the suppressive effect of tranilast, an antiallergic drug inhibiting mediator release from mast cells, on fibrosis. Int Arch Allergy Appl Immunol 1991; 95:195-201.
41. Walker M, Harley R, Maize J, DeLustro F, LeRoy EC. Mast cells and their granulation in the TSK mouse model of scleroderma. Proc Soc Exp Biol Med 1985;180:323-8.
42. Denholm EM, Phan SH. The effects of bleomycin on alveolar macrophage growth factor secretion. Am J Pathol 1989;134:355-63.
43. Kovacs EJ, Kelley J. Secretion of macrophage-derived growth factor during acute lung injury by bleomycin. J Leukocyte Biol 1985; 37:1-14.
44. Yamamoto T, Katayama I, Nishioka K. Fibroblast proliferation by bleomycin-stimulated peripheral blood mononuclear cell factors. J Rheumatol 1999;26:609-15.
45. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
46. Piquet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63.
47. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC, Crystal RG. Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest 1988;82:1685-93.
48. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989;170:727-37.
49. Zhang K, Gharaee-Kermani M, McGarry B, Remick D, Phan SH. TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol 1997;158:954-9.
50. Wallace VA, Kondo S, Kono T, et al. A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur J Immunol 1994;24:1463-6.